Justices Urged To Fix Fed. Circ. 'Paradox' In Heart Drug Case

By Tiffany Hu (February 24, 2021, 7:44 PM EST) -- Inventor group U.S. Inventor is asking the U.S. Supreme Court to take up Amarin Pharma's appeal of the Federal Circuit's decision to strike down six patents on its heart drug Vascepa, saying the appeals court has created a "jurisprudential paradox" in how it analyzes obviousness....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!